Pineridge Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-55
Closed -$9.29K 476
2025
Q2
$9.29K Hold
55
﹤0.01% 229
2025
Q1
$7.59K Sell
55
-108
-66% -$13.8K ﹤0.01% 269
2024
Q4
$19.3K Buy
163
+130
+394% +$15.2K 0.01% 228
2024
Q3
$3.61K Buy
33
+7
+27% +$732 ﹤0.01% 386
2024
Q2
$2.51K Buy
26
+1
+4% +$102 ﹤0.01% 458
2024
Q1
$2.85K Sell
25
-13
-34% -$1.4K ﹤0.01% 432
2023
Q4
$3.86K Buy
+38
New +$3.77K ﹤0.01% 537

Other funds holding CAH

Pineridge Advisors's CAH Position: Q3 2025 in Review

Pineridge Advisors sold out of Cardinal Health (CAH) in Q3 2025, closing a stake of 55 shares — an estimated $9.29K sold.

Pineridge Advisors first reported a position in CAH in Q4 2023 and held it in 7 quarters. The position peaked at $19.3K in Q4 2024. 1,222 funds tracked by Wall St. Rank hold CAH as of Q3 2025.

  • Pineridge Advisors reported no remaining Cardinal Health position as of Q3 2025 after selling out during the quarter.
  • Pineridge Advisors sold 55 Cardinal Health shares in Q3 2025, an estimated $9.29K.
  • Pineridge Advisors first reported a position in Cardinal Health in Q4 2023 and held it in 7 quarters.
  • Pineridge Advisors's Cardinal Health position peaked at $19.3K in Q4 2024.
  • 1,222 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2025.

Based on Pineridge Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.